db x-trackers II iBoxx Liquid Corporate Financials UCITS 1C is a bonds ETF from Xtrackers tracking the db x-trackers iBoxx Liquid Corporate Financials index through physical replication. Domiciled in Luxembourg and launched in 2010, the fund manages about 2 bn € and charges a TER of 0.16% — 16 € per year on a €10,000 investment. Income is automatically reinvested in the fund (accumulating).
db x-trackers II iBoxx Liquid Corporate Financials UCITS 1C competes with 365 other products in the same class and region (Bonds, Global): it ranks 39th by fund size and 200th by ongoing cost, with a TER of 0.16% against a group median of 0.15%. It has been listed since 2010, 16 years of track record.
On a €10,000 investment the TER costs 16 € a year, against 15 € for the median product in the category.
Replication is physical: the fund holds the underlying securities directly. The ten largest positions account for 1.6% of the portfolio.
Income is accumulated: no distribution is paid out, the share price absorbs it. In a savings plan this removes the need to reinvest dividends by hand. The fund is denominated in EUR. That is not the same as currency risk: the exposure comes from the currencies of the underlying holdings, not from the denomination or the trading currency of a given listing.
The fund is domiciled in Luxembourg, which determines the tax treatment of income received by the fund and the supervisory authority.
| Cooperatieve Rabobank U.A. 4.125% | 0.2% |
| Cooperatieve Rabobank U.A. 4.12% | 0.2% |
| Orange S.A. 8.125% | 0.2% |
| Deutsche Bank AG 1.625% | 0.2% |
| Deutsche Bank AG 1.62% | 0.2% |
| Orange S.A. 8.12% | 0.2% |
| Sanofi 1.38% | 0.1% |
| BNP Paribas 2.12% | 0.1% |
| Sanofi 1.375% | 0.1% |
| Microsoft Corporation 3.125% | 0.1% |
| Borsa Italiana | XB4F | EUR |
| XETRA | XB4F | EUR |
| Francoforte | XB4F | EUR |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.